VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Canarypox virus

Table of Contents
  1. General Information
    1. NCBI Taxonomy ID
    2. Disease
    3. Introduction
    4. Host Ranges and Animal Models
  2. Vaccine Information
    1. Canary Pox Modified Live Virus Vaccine (USDA: 1623.10)
  3. References
I. General Information
1. NCBI Taxonomy ID:
44088
2. Disease:
Canary Pox
3. Introduction
Canarypox virus (CNPV) is an avipoxvirus and etiologic agent of canarypox, a disease of birds both in the wild and in commercial aviaries, where significant losses result. Canarypox has been described broadly as the poxviral disease of passeriform (song) birds, efficiently causing disease in passerine hosts compared to galliform (domestic fowl) and columbiform (pigeon) hosts. However, passerine host preferences exist, and current International Committee on Taxonomy of Viruses classification differentiates between CNPV and several other passerine isolates. CNPV produces clinical signs similar to generalized poxviral infections of other birds, including both cutaneous and diptheretic disease forms caused by the prototypical galliform avipoxvirus, fowlpox virus (FWPV), and including proliferative and necrotic changes in epithelial tissues of the dermis, notably around the eyes and commissures of the beak, feet, and respiratory tract. Canarypox, however, is generally associated with higher mortality rates than seen in fowlpox, commonly approaching 100%, and may occur without characteristic skin lesions. Histologically and ultrastructurally, CNPV undergoes morphogenic stages similar to FWPV and other chordopoxviruses (ChPV), causing type A and B intracytoplasmic inclusions in epithelial and mononuclear cells of permissive hosts; however, CNPV may have a broader tissue tropism than FWPV (Tulman et al., 2004).
4. Host Ranges and Animal Models
Passeriform (song) birds (Tulman et al., 2004).
II. Vaccine Information
1. Canary Pox Modified Live Virus Vaccine (USDA: 1623.10)
a. Manufacturer:
Biomune Company
b. Vaccine Ontology ID:
VO_0001530
c. Type:
Live, attenuated vaccine
d. Status:
Licensed
e. Location Licensed:
USA
f. Host Species for Licensed Use:
Birds
III. References